There are deficits, big holes, and the question is, how can the Channel Islands fill them? The solutions are not pretty - voluntary redundancies, compulsory redundancies, new taxes, public sector cuts. Simply put, the archipelago needs more tax revenue and less public spending. Prohibition Partners examines why the Channel Islands need to implement a medicinal cannabis industry.
Austria has one of the most complicated positions on the legality of medical cannabis. The Alpine country has a rich history of hemp production and a burgeoning cannabis industry from Vienna to Salzburg, however, the election of right-leaning conservative, Sebastian Kurz, may spell troubling times for the cannabis community. As part of our European Country Review, Prohibition Partners looks to navigate through the convoluted system of the Austrian cannabis industry.
Historically a country with complex and turbulent drug laws, Prohibition Partners explores any recent changes in Belgian legislation, given the dramatic policy changes sweeping mainland Europe in 2017.
Throughout 2017, Malta has seen a slow but steady shift towards medical cannabis legalisation. Last month, a proposal put forth to the Maltese government that aims to facilitate the prescription of medical cannabis by general practitioners.
Saturday, 18th November marked a historic moment in the progression of medicinal cannabis treatment in Ireland. The Department of Health approved a three-month licence for tetrahydrocannabinol (THC) for the treatment of severe chronic pain.
With only a limited number of licences available for the recently announced Danish medical cannabis trial, the race is on to submit applications in advance of the deadline on the 31st of December. We explore the process and opportunity.
Europe is set to become the largest legal cannabis market in the world within the next five years.
Our report provides a detailed analysis of the medical, recreational and industrial sectors in 15 key European markets in addition to the various commercial, legal and social developments across the region.
There is currently a tide of cannabis reform sweeping throughout Europe, yet there is still a small number of states who have yet to make any effort on reform. This contrast in approach is reflected throughout Scandinavia - although there is still a long way to go before any of these countries become European forerunners.
Historically, Portugal is regarded as somewhat of a trailblazer when it comes to drug reform. Yet in the 15+ years that have followed, very little progress has been made and so Portugal seems set to remain rooted to its restrictive and inconsistent legal stance.
The New Opium Act was implemented in the Netherlands in 1976, which was to lead the way for the so called ‘Policy of Tolerance’. Initially, the policy was meant as a first step towards full regulation of soft drugs - although here we are 40 years later with very little progress.